Question 1

What is LOPJLB’s current signal on IBIO?

Accepted Answer

LOPJLB’s latest quantitative signal on iBio, Inc. (IBIO) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is IBIO in?

Accepted Answer

iBio, Inc. (IBIO) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does iBio, Inc. (IBIO) do?

Accepted Answer

iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through investigational new drug (IND) development, aimed at…

Question 4

Where is iBio, Inc. based / listed?

Accepted Answer

iBio, Inc. is based in US, listed on NASDAQ.

iBio, Inc. (IBIO)

Key stats

Prediction markets

Company news